written by reader Matthew Carr’s “Trailblazer Pro” and its “Living Medicine”

By taubie, September 16, 2020

Carr touts his Living Medicine penny stocks at $2000.00 to sign up. Does anyone know what stocks he is talking about?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

8 Comments
Inline Feedbacks
View all comments
acamrud
Irregular
acamrud
September 18, 2020 11:26 am

Dr Gumshoe what do you know?

JohnnyP
Guest
JohnnyP
September 22, 2020 8:21 pm
Reply to  acamrud

A couple of them are easy to guess.
– The Mr Wonderful backed company is dfinitely Mind Medicine (MMEDF).
– The “$5 stock with record $33 million revenue” is now a $15 stock called GROW GENERATION (GRWG)…which used to be $5 bucks a couple months back.
– The company which just completed a major acquisition with the right to 2 separate phase 1 trials and has secured a partnership with Intervivo Solutions is Champignon Brands (SHRMF.)

Not sure about the other three.

Jeff W.
Guest
Jeff W.
September 23, 2020 1:42 am
Reply to  acamrud

They just listed on the CSE:
https://mindcure.com/about-us/about/

krkingsley
Irregular
September 19, 2020 12:11 pm

Yes, I’m reading about this too and wonder the same thing as an Oxford Subscriber

👍 3
Jeff W.
Guest
Jeff W.
September 19, 2020 3:56 pm
Reply to  krkingsley

Mr. Wonderful likes this too…

Jeff W.
Guest
Jeff W.
September 19, 2020 4:02 pm
Reply to  krkingsley

I don’t think my link referral worked. Here it is:

http://www.mindmed.co

Jeff W.
Guest
Jeff W.
September 19, 2020 4:19 pm

I’ve recently done some research. This is an exciting time to get in for sure!
Here’s a good source:

https://psychedelicstockwatch.com/thank-you/thank-you-page-pre-ipo

Jeff W.
Guest
Jeff W.
September 27, 2020 9:38 pm

Another one still…
Obviously growing trend and competition – a good thing!

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info